Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulfatase (rhASB) enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

被引：0
|
作者：
Harmatz, P
Whitley, C
Steiner, R
Plecko, B
Kaplan, P
Waterson, J
Ketteridge, D
Giugliani, R
Schwartz, I
Guffon, N
Miranda, CS
Keppen, L
Teles, EL
Kramer, WG
Hopwood, JJ
机构：
[1] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[2] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[3] Graz Univ, Kinderklin, A-8010 Graz, Austria
[4] Childrens Hosp Philadelphia, Philadelphia, PA USA
[5] Womens & Childrens Hosp, Adelaide, SA, Australia
[6] Hospl Clin Porto Alegre, Porto Alegre, RS, Brazil
[7] Hosp Edouard Herriot, Lyon, France
[8] Univ S Dakota, Vermillion, SD 57069 USA
[9] Hosp Sao Joao, Oporto, Portugal
[10] Kramer Consulting LLC, N Potomac, MD USA
[11] Childrens Hosp & Res Ctr, Oakland, CA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2004年 / 81卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 45 条
  • [21] Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis
    Munoz-Rojas, Maria Veronica
    Gandelman Horovitz, Dafne Dain
    Jardim, Laura Bannach
    Raymundo, Marcia
    Llerena, Juan Clinton, Jr.
    Carneiro Pacheco de Magalhaes, Tatiana de Sa
    Vieira, Taiane Alves
    Costa, Ronaldo
    Kakkis, Emil
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (04) : 346 - 350
  • [22] Enzyme replacement therapy for mucopolysaccharidosis VI: A Phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
    Harmatz, Paul
    Giugliani, Roberto
    Schwariz, Ida
    Guffon, Nathaue
    Teles, Eusa Leao
    Miranda, M. Clara Sa
    Wraith, J. Edmond
    Beck, Michael
    Arash, Lapp
    Scarpa, Maurilo
    Yu, Zi-Fan
    Wittes, Janet
    Berger, Kenneth I.
    Newman, Mary S.
    Lowe, Ann M.
    Kakkis, Emil
    Swiedler, Stuart J.
    JOURNAL OF PEDIATRICS, 2006, 148 (04): : 533 - 539
  • [23] Six years experience of enzyme replacement therapy (ERT) with recombinant human arylsulfatase B (rhASB) in an 18 year old male with MPS VI (Maroteaux-Lamy)
    Brunner-Krainz, M.
    Harmatz, P.
    Pfleger, A.
    Eber, E.
    Zach, M.
    Roedl, S.
    Paschke, E.
    Plecko, B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 116 - 116
  • [24] Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI:: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
    Harmatz, Paul
    Giugliani, Roberto
    Schwartz, Ida Vanessa D.
    Guffon, Nathalie
    Teles, Elisa Leao
    Miranda, M. Clara Sa
    Wraith, J. Edmond
    Beck, Michael
    Arash, Laila
    Scarpa, Maurizio
    Ketteridge, David
    Hopwood, John J.
    Plecko, Barbara
    Steiner, Robert
    Whitley, Chester B.
    Kaplan, Paige
    Yu, Zi-Fan
    Swiedler, Stuart J.
    Decker, Celeste
    MOLECULAR GENETICS AND METABOLISM, 2008, 94 (04) : 469 - 475
  • [25] Long term safety and efficacy of enzyme replacement therapy for MPS VI (Maroteaux-Lamy syndrome)
    Harmatz, Paul
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S18 - S18
  • [26] HUMAN N-ACETYLGALACTOSAMINE-4-SULFATASE BIOSYNTHESIS AND MATURATION IN NORMAL, MAROTEAUX-LAMY AND MULTIPLE-SULFATASE-DEFICIENT FIBROBLASTS
    TAYLOR, JA
    GIBSON, GJ
    BROOKS, DA
    HOPWOOD, JJ
    BIOCHEMICAL JOURNAL, 1990, 268 (02) : 379 - 386
  • [27] Regulation of N-acetylgalactosamine 4-sulfatase expression in retrovirus-transduced feline mucopolysaccharidosis type VI muscle cells
    Yogalingam, G
    Muller, V
    Hopwood, JJ
    Anson, DS
    DNA AND CELL BIOLOGY, 1999, 18 (03) : 187 - 195
  • [28] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, MULTINATIONAL CLINICAL STUDY OF RECOMBINANT HUMAN N-ACETYLGALACTOSAMINE 4 SULFATASE (RHASB) IN PATIENTS WITH MUCOPOLYSACCHARIDOSIS VI
    Guffon, N.
    Harmatz, P.
    Giugliani, R.
    Schwartz, I.
    Miranda, C.
    Teles, E.
    Wraith, Ed
    Beck, M.
    Arash, L.
    Scarpa, M.
    Swiedler, S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 190 - 190
  • [29] Fifteen years of enzyme replacement therapy for mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome): a case report
    Isadora Andrade
    River Ribeiro
    Zumira A. Carneiro
    Roberto Giugliani
    Catarina Pereira
    Claudia Cozma
    Daniel Grinberg
    Lluïsa Vilageliu
    Charles M. Lourenco
    Journal of Medical Case Reports, 16
  • [30] Aortic and Mitral Valve Involvement in Maroteaux-Lamy Syndrome VI: Surgical Implications in the Enzyme Replacement Therapy Era
    Torre, Salvatore
    Scarpelli, Mauro
    Salviati, Alessandro
    Buffone, Ebba
    Faggian, Giuseppe
    Luciani, Giovanni Battista
    ANNALS OF THORACIC SURGERY, 2016, 102 (01): : E23 - E25
12345